机译:P3.13-16在非小细胞肺癌患者中伴随EML4-ALK重排和EGFR突变:来自东方印度医院的数据。
Pulmonary Medicine All India Institute of Medical Sciences;
Pulmonary Medicine All India Institute of Medical Sciences;
Pulmonary Medicine All India Institute of Medical Sciences;
Pathology All India Institute of Medical Sciences;
Pathology All India Institute of Medical Sciences;
Pathology All India Institute of Medical Sciences;
Radiotherapy All India Institute of Medical Sciences;
Radiodiagnosis All India Institute of Medical Sciences;
Radiodiagnosis All India Institute of Medical Sciences;
Pulmonary Medicine All India Institute of Medical Sciences;
Pulmonary Medicine All India Institute of Medical Sciences;
Pulmonary Medicine All India Institute of Medical Sciences;
Pulmonary Medicine All India Institute of Medical Sciences;
Pulmonary Medicine All India Institute of Medical Sciences;
Pulmonary Medicine All India Institute of Medical Sciences;
Surgical Oncology All India Institute of Medical Sciences;
机译:P3.13-16在非小细胞肺癌患者中伴随EML4-ALK重排和EGFR突变:来自东方印度医院的数据。
机译:伴随印度的非小细胞肺癌患者的非小细胞肺癌患者中伴随的棘皮药相关蛋白样4- an-塑料淋巴瘤激酶重排和表皮生长因子受体突变
机译:具有EGFR突变相关临床特征的非小细胞肺癌患者EML4-ALK融合基因的检测
机译:接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
机译:TNFAIP8组合对非小细胞肺癌细胞EGFR和IGF-1R信号传导及靶向药物的细胞毒性的影响
机译:非小细胞肺癌患者伴随EML4-ALK重排和EGFR突变:文献复习100例
机译:低收入印度印度患者的治疗模式,包括EGFR突变或ALK重排的转移性非小细胞肺癌